Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.
Fujimoto, Ayumi
Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. [electronic resource] - Hematological oncology Apr 2020 - 146-152 p. digital
Publication Type: Journal Article; Multicenter Study
1099-1069
10.1002/hon.2714 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological--therapeutic use
Combined Modality Therapy
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation--methods
Humans
Incidence
Japan--epidemiology
Lymphoma, B-Cell--pathology
Lymphoproliferative Disorders--epidemiology
Male
Middle Aged
Prognosis
Retrospective Studies
Rituximab--therapeutic use
Survival Rate
Transplantation, Homologous
Young Adult
Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. [electronic resource] - Hematological oncology Apr 2020 - 146-152 p. digital
Publication Type: Journal Article; Multicenter Study
1099-1069
10.1002/hon.2714 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological--therapeutic use
Combined Modality Therapy
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation--methods
Humans
Incidence
Japan--epidemiology
Lymphoma, B-Cell--pathology
Lymphoproliferative Disorders--epidemiology
Male
Middle Aged
Prognosis
Retrospective Studies
Rituximab--therapeutic use
Survival Rate
Transplantation, Homologous
Young Adult